Henry Schein (HSIC) Tops Q3 EPS by 15c, provides guidance

Henry Schein (NASDAQ: HSIC) reported Q3 EPS of $1.32, $0.15 better than the analyst estimate of $1.17. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.24 billion.

GUIDANCE:

Henry Schein sees FY2024 EPS of $4.74-$4.82, versus the consensus of $4.75. 2024 total sales growth is now expected to be 4% to 5% over 2023, compared with prior guidance of 4% to 6% growth. 2024 Adjusted EBITDA is expected to grow in the low-double-digit percentages versus 2023 Adjusted EBITDA, and is unchanged compared to prior guidance.

For earnings history and earnings-related data on Henry Schein (HSIC) click here.

You May Also Be Interested In

• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
• CLSA Reiterates Outperform (2) Rating on Hexaware Technologies (HEXW:IN)
• Hanmi Pharm licenses obesity drug to Genentech in $2.3B deal